JANE STREET GROUP, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2024$44,391
-63.4%
28,456
-54.2%
0.00%
Q1 2024$121,173
+317.8%
62,140
+511.8%
0.00%
Q2 2022$29,000
-71.6%
10,157
-25.9%
0.00%
Q4 2021$102,000
-96.9%
13,700
-96.2%
0.00%
-100.0%
Q3 2021$3,267,000359,9010.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tikvah Management LLC 1,350,833$3,823,0001.65%
Telemetry Investments, L.L.C. 447,000$1,265,0001.50%
Stonepine Capital Management, LLC 601,580$1,702,0000.79%
VR Adviser, LLC 1,398,889$3,959,0000.78%
TANG CAPITAL MANAGEMENT LLC 1,113,453$3,151,0000.48%
Deep Track Capital, LP 290,844$823,0000.05%
FEDERATED HERMES, INC. 5,222,250$14,779,0000.04%
Alyeska Investment Group, L.P. 972,326$2,752,0000.03%
Baker Brothers Advisors 374,395$1,060,0000.01%
Virtu Financial LLC 12,845$36,0000.00%
View complete list of ATYR PHARMA INC shareholders